ELONGIN BC (XX01TCEB1A-c001) Citations (4)

Originally described in: SGC Oxford April 2018 plasmids
Unpublished

Articles Citing ELONGIN BC (XX01TCEB1A-c001)

Articles
An In Vitro Pull-down Assay of the E3 Ligase:PROTAC:Substrate Ternary Complex to Identify Effective PROTACs. Bondeson DP, Smith BE, Buhimschi AD. Methods Mol Biol. 2021;2365:135-150. doi: 10.1007/978-1-0716-1665-9_7. PubMed
Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity. Lv D, Pal P, Liu X, Jia Y, Thummuri D, Zhang P, Hu W, Pei J, Zhang Q, Zhou S, Khan S, Zhang X, Hua N, Yang Q, Arango S, Zhang W, Nayak D, Olsen SK, Weintraub ST, Hromas R, Konopleva M, Yuan Y, Zheng G, Zhou D. Nat Commun. 2021 Nov 25;12(1):6896. doi: 10.1038/s41467-021-27210-x. PubMed
Human Protein-l-isoaspartate O-Methyltransferase Domain-Containing Protein 1 (PCMTD1) Associates with Cullin-RING Ligase Proteins. Warmack RA, Pang EZ, Peluso E, Lowenson JD, Ong JY, Torres JZ, Clarke SG. Biochemistry. 2022 May 17;61(10):879-894. doi: 10.1021/acs.biochem.2c00130. Epub 2022 Apr 29. PubMed
Development and crystal structures of a potent second-generation dual degrader of BCL-2 and BCL-xL. Nayak D, Lv D, Yuan Y, Zhang P, Hu W, Nayak A, Ruben EA, Lv Z, Sung P, Hromas R, Zheng G, Zhou D, Olsen SK. Nat Commun. 2024 Mar 29;15(1):2743. doi: 10.1038/s41467-024-46922-4. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.